Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. ESTA
stocks logo

ESTA

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
63.87M
+43.48%
-0.218
-81.68%
56.42M
+36.35%
-0.462
-34.02%
64.95M
+26.62%
-0.296
-47.98%
Estimates Revision
The market is revising Upward the revenue expectations for Establishment Labs Holdings Inc. (ESTA) for FY2025, with the revenue forecasts being adjusted by 0.7% over the past three months. During the same period, the stock price has changed by 81.17%.
Revenue Estimates for FY2025
Revise Upward
up Image
+0.7%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-10.46%
In Past 3 Month
Stock Price
Go Up
up Image
+81.17%
In Past 3 Month
Wall Street analysts forecast ESTA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ESTA is 71.75 USD with a low forecast of 43.00 USD and a high forecast of 85.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
8 Analyst Rating
Wall Street analysts forecast ESTA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ESTA is 71.75 USD with a low forecast of 43.00 USD and a high forecast of 85.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Buy
1 Hold
0 Sell
Strong Buy
Current: 70.710
sliders
Low
43.00
Averages
71.75
High
85.00
Current: 70.710
sliders
Low
43.00
Averages
71.75
High
85.00
BTIG
Buy
maintain
$70 -> $81
2025-11-14
Reason
BTIG
Price Target
$70 -> $81
2025-11-14
maintain
Buy
Reason
BTIG raised the firm's price target on Establishment Labs to $81 from $70 and keeps a Buy rating on the shares. To get a better idea of Motiva adoption trends and market share shifts over the coming years, the firm conducted a brief poll of 33 U.S. plastic surgeons who perform aesthetic breast augmentations in the week following the company's Q3 earnings call, and the polled surgeons anticipate the market will remain healthy, with procedural volumes expected to increase at a 14% CAGR from 2025-2027, the analyst tells investors in a research note.
JPMorgan
Allen Gong
Overweight
maintain
$45 -> $71
2025-11-06
Reason
JPMorgan
Allen Gong
Price Target
$45 -> $71
2025-11-06
maintain
Overweight
Reason
JPMorgan analyst Allen Gong raised the firm's price target on Establishment Labs to $71 from $45 and keeps an Overweight rating on the shares. The company reported good Q3 results on better profitability, the analyst tells investors in a research note.
Canaccord
Buy
maintain
$60 -> $72
2025-11-06
Reason
Canaccord
Price Target
$60 -> $72
2025-11-06
maintain
Buy
Reason
Canaccord raised the firm's price target on Establishment Labs to $72 from $60 and keeps a Buy rating on the shares. The firm said they posted a strong quarter with top-line results exceeding expectations, growing 34% year-over-year, while achieving its first quarter of EBITDA positivity.
Needham
NULL -> Buy
upgrade
$48 -> $70
2025-11-06
Reason
Needham
Price Target
$48 -> $70
2025-11-06
upgrade
NULL -> Buy
Reason
Needham raised the firm's price target on Establishment Labs to $70 from $48 and keeps a Buy rating on the shares. The company's Q3 revenue and adjusted EBITDA beat consensus, and the management now expects 2025 revenue to exceed the mid-point of its former revenue guidance range, the analyst tells investors in a research note.
Mizuho
Outperform
maintain
$70 -> $85
2025-11-06
Reason
Mizuho
Price Target
$70 -> $85
2025-11-06
maintain
Outperform
Reason
Mizuho raised the firm's price target on Establishment Labs to $85 from $70 and keeps an Outperform rating on the shares. The company reported better than expected Q3 results with its first quarter of positive EBITDA, the analyst tells investors in a research note. The firm believes that at least a doubling of U.S. Motiva sales in 2026 is highly achievable on a combination of deeper existing account penetration along with new site adds. Establishment remains a top pick at Mizuho.
Canaccord
initiated
$60
2025-08-20
Reason
Canaccord
Price Target
$60
2025-08-20
initiated
Reason
Canaccord initiated coverage of Establishment Labs with a Buy rating and $60 price target. The company's portfolio is positioned to win considerable share in the U.S. market as its launch continues and it submits more indications to the FDA, the analyst tells investors in a research note. The firm says Establishment is seeking expand its total addressable market to patients who were previously unlikely to undergo breast augmentations with the launch of its smaller implant, minimally invasive procedure named Mia.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Establishment Labs Holdings Inc (ESTA.O) is -56.65, compared to its 5-year average forward P/E of -32.64. For a more detailed relative valuation and DCF analysis to assess Establishment Labs Holdings Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-32.64
Current PE
-56.65
Overvalued PE
-14.30
Undervalued PE
-50.97

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-93.67
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
22.00
Undervalued EV/EBITDA
-209.35

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
7.94
Current PS
0.00
Overvalued PS
10.61
Undervalued PS
5.27
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds areSelling! The selling amount has increased 348.78% over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

ESTA News & Events

Events Timeline

(ET)
2025-11-05
08:32:40
Establishment Labs announces Q3 earnings per share of 38 cents, below consensus estimate of 51 cents.
select
2025-10-14 (ET)
2025-10-14
08:20:48
Establishment Labs Releases Mia Femtech Findings in Aesthetic Surgery Journal
select
2025-08-07 (ET)
2025-08-07
09:10:57
Establishment Labs reports Q2 EPS (57c), consensus (56c)
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
5.0
11-20NASDAQ.COM
17.0% of FHLC Holdings Experiencing Recent Insider Purchases

  • Insider Buying Activity: 17.0% of the weighted holdings in the Fidelity MSCI Health Care Index ETF (FHLC) have seen insider buying in the past six months.

  • Avantor Inc (AVTR): This company, making up 0.12% of FHLC, has had two directors and officers purchase shares recently, with the ETF holding $3,215,377 worth of AVTR.

  • Establishment Labs Holdings Inc (ESTA): Representing approximately 0.02% of FHLC, ESTA has also seen insider purchases from two directors and officers, with the ETF holding $490,723 worth of ESTA.

  • Disclaimer: The views expressed in the article are those of the author and do not necessarily reflect the opinions of Nasdaq, Inc.

[object Object]
Preview
9.5
11-18Yahoo Finance
Establishment Labs Holdings (ESTA) Rises Over 27% Following Q3 2025 Earnings Report

  • Company Performance: Establishment Labs Holdings Inc. (NASDAQ: ESTA) reported Q3 2025 revenue of $53.78 million, a 33.7% year-over-year increase, exceeding analyst estimates by $1.5 million, while the EPS of negative $0.38 also surpassed expectations.

  • Growth in US Market: The company's US business, a key growth area, saw a 16% increase despite a seasonally slower quarter for breast procedures, with management anticipating a 20% market share in US breast augmentation by the end of 2025.

  • Sales Acceleration: Management noted that the fourth quarter is typically the strongest for breast augmentation, and they are already observing sales acceleration in the US market.

  • Investment Considerations: While ESTA shows potential as an investment, the article suggests that certain AI stocks may offer better upside potential and lower downside risk.

[object Object]
Preview
4.0
11-14Benzinga
BTIG Reaffirms Buy Rating for Establishment Labs Holdings, Increases Price Target to $81

  • Real-time Intelligence: Benzinga Pro offers the fastest news alerts for traders, helping them stay informed and make timely decisions in the stock market.

  • Exclusive Content: The platform provides exclusive stories and insights generated by Benzinga reporters, enhancing the trading experience for its users.

  • Community Engagement: Over 10,000 serious traders are part of the Benzinga Pro community, indicating a robust network for sharing market intelligence.

  • Market Winning Tools: Benzinga Pro is designed to equip traders with the tools and information necessary to succeed in the markets daily.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Establishment Labs Holdings Inc (ESTA) stock price today?

The current price of ESTA is 70.71 USD — it has increased 4.35 % in the last trading day.

arrow icon

What is Establishment Labs Holdings Inc (ESTA)'s business?

Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers.

arrow icon

What is the price predicton of ESTA Stock?

Wall Street analysts forecast ESTA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ESTA is 71.75 USD with a low forecast of 43.00 USD and a high forecast of 85.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Establishment Labs Holdings Inc (ESTA)'s revenue for the last quarter?

Establishment Labs Holdings Inc revenue for the last quarter amounts to 53.78M USD, increased 33.70 % YoY.

arrow icon

What is Establishment Labs Holdings Inc (ESTA)'s earnings per share (EPS) for the last quarter?

Establishment Labs Holdings Inc. EPS for the last quarter amounts to -0.38 USD, decreased -35.59 % YoY.

arrow icon

What changes have occurred in the market's expectations for Establishment Labs Holdings Inc (ESTA)'s fundamentals?

The market is revising Upward the revenue expectations for Establishment Labs Holdings Inc. (ESTA) for FY2025, with the revenue forecasts being adjusted by 0.7% over the past three months. During the same period, the stock price has changed by 81.17%.
arrow icon

How many employees does Establishment Labs Holdings Inc (ESTA). have?

Establishment Labs Holdings Inc (ESTA) has 1018 emplpoyees as of December 05 2025.

arrow icon

What is Establishment Labs Holdings Inc (ESTA) market cap?

Today ESTA has the market capitalization of 2.05B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free